Cresset Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-80,000
Closed -$13.2M 1893
2023
Q2
$13.2M Buy
+80,000
New +$12.9M 0.02% 226

Other funds holding JNJ

Cresset Asset Management's JNJ Position: Q1 2026 in Review

Cresset Asset Management reduced its Johnson & Johnson (JNJ) stake by 6.9% in Q1 2026, selling an estimated $5.86M and leaving 337,210 shares worth $82.4M. The position accounts for 0.36% of the portfolio, ranked #45.

Cresset Asset Management first reported a position in JNJ in Q4 2018 and has held it in 30 quarters since. The position peaked at $90.5M in Q3 2024. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Cresset Asset Management held 337,210 shares of Johnson & Johnson worth $82.4M as of Q1 2026.
  • Cresset Asset Management sold 25,137 Johnson & Johnson shares in Q1 2026, an estimated $5.86M.
  • Johnson & Johnson made up 0.36% of Cresset Asset Management's portfolio in Q1 2026, its #45 holding.
  • Cresset Asset Management first reported a position in Johnson & Johnson in Q4 2018 and has held it in 30 quarters since.
  • Cresset Asset Management's Johnson & Johnson position peaked at $90.5M in Q3 2024.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.